BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21943937)

  • 1. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivation of implantable cardioverter-defibrillators at end of life.
    Pettit SJ; Jackson CE; Gardner RS
    Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
    Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
    Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of implantable cardioverter-defibrillators in terminal illness and end-of-life care.
    Raphael CE
    Am J Cardiol; 2012 May; 109(9):1384. PubMed ID: 22500604
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of patients with ICDs at the end of life (EOL): a qualitative study.
    Kelley AS; Mehta SS; Reid MC
    Am J Hosp Palliat Care; 2008 Dec-2009 Jan; 25(6):440-6. PubMed ID: 18812618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
    Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
    Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
    Niewald A; Broxterman J; Rosell T; Rigler S
    J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses.
    Trussler A; Alexander B; Campbell D; Alhammad N; Enriquez A; Chacko S; Garrett T; Simpson C; Redfearn D; Abdollah H; Herx L; Baranchuk A
    Am J Cardiol; 2019 Oct; 124(7):1064-1068. PubMed ID: 31353003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethics of unilateral implantable cardioverter defibrillators and cardiac resynchronization therapy with defibrillator deactivation: patient perspectives.
    Daeschler M; Verdino RJ; Kirkpatrick JN
    Europace; 2017 Aug; 19(8):1343-1348. PubMed ID: 27915265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study.
    Matlock DD; Nowels CT; Masoudi FA; Sauer WH; Bekelman DB; Main DS; Kutner JS
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1634-44. PubMed ID: 21972983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deactivation of automatic implantable cardioverter-defibrillators in hospice and home care patients at the end of life.
    Kirk TW
    Home Healthc Nurse; 2008; 26(7):431-7. PubMed ID: 18622221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICD recipients' understanding of ethical issues, ICD function, and practical consequences of withdrawing the ICD in the end-of-life.
    Strömberg A; Fluur C; Miller J; Chung ML; Moser DK; Thylén I
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):834-42. PubMed ID: 24483943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator deactivation: a hospice quality improvement initiative.
    Kraynik SE; Casarett DJ; Corcoran AM
    J Pain Symptom Manage; 2014 Sep; 48(3):471-7. PubMed ID: 24480530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do implantable cardioverter defibrillators complicate end-of-life care for those with heart failure?
    Waterhouse E; Ahmad F
    Curr Opin Support Palliat Care; 2011 Dec; 5(4):307-11. PubMed ID: 22025091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinician Attitudes Regarding ICD Deactivation in DNR/DNI Patients.
    Bradley A; Marks A
    J Hosp Med; 2017 Jul; 12(7):498-502. PubMed ID: 28699936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.